Orforglipron may be a safe and effective oral GLP-1 agonist for treatment of type 2 diabetes
Bookmark1. Patients assigned to orforglipron experienced significant reductions in HbA1c, and body...
Read MoreAug 17, 2023
Bookmark1. Patients assigned to orforglipron experienced significant reductions in HbA1c, and body...
Read MoreAug 16, 2023
Bookmark1. Median overall survival in the atezolizumab group was 10.3 months versus 9.2 months in...
Read MoreAug 15, 2023
Bookmark1. The pathological complete response rate for the experimental group was improved...
Read MoreAug 15, 2023
Bookmark1. At 24 months, more participants in the pembrolizumab group were alive without an event,...
Read MoreAug 15, 2023
Bookmark1. There was no statistically significant difference in recovery time in patients with...
Read MoreAug 14, 2023
Bookmark1. Anxiety and depression were more prevalent among individuals with eczema or psoriasis,...
Read MoreAug 13, 2023
Bookmark1. Compared to healthy controls, participants with a first episode of schizophrenia had...
Read MoreAug 12, 2023
Bookmark1. In this randomized controlled trial, dupilumab use was associated with significantly...
Read MoreAug 11, 2023
Bookmark1. Dupilumab treatment for bullous pemphigoids resulted in improved clinical symptoms. 2....
Read MoreAug 10, 2023
Bookmark1. Implementation of ‘Water First’, a program consisting of classroom lessons, water...
Read MoreAug 10, 2023
Bookmark1. In this randomized controlled trial, zilebesiran resulted in reduced serum...
Read MoreAug 10, 2023
Bookmark1. Mean pain score at 6 weeks was not statistically different between the opioid and...
Read MoreAug 10, 2023
Bookmark1. Among those treated for Hepatitis C Virus (HCV) infection, leading causes of death...
Read MoreAug 9, 2023
Bookmark1. In this observational study, long-acting antiretroviral therapy (LA-ART) was effective...
Read MoreAug 9, 2023
Bookmark1. Progression-free survival was significantly higher in the talazoparib plus enzalutamide...
Read MoreAug 8, 2023
Bookmark1. Initiating colorectal cancer screening at age 45 results in 12,188 fewer cases and...
Read MoreAug 8, 2023
Bookmark1. The immune subtype demonstrated an improved progression-free survival (HR 0.37) and...
Read MoreAug 8, 2023
Bookmark1. In this randomized controlled trial, weekly insulin icodec use resulted in better...
Read MoreAug 5, 2023
Bookmark1. In this population cohort study, patients with gout who used sodium-glucose...
Read MoreAug 4, 2023
Bookmark1. In a randomized control trial of the social care screening program WE CARE, health...
Read More